Survey on cancer drug benefits and patient preferences
Part of Cancer clinical trials.
This trial asks cancer patients about their thoughts on new cancer drugs and what they would prefer in treatment. You'll fill out a short survey to share your views.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a current or former cancer patient (any type except nonmelanoma skin cancer).
- You are 18 years old or older.
- You are fluent in English.
- You live in the United States.
- You will take a survey that takes at least 2 and a half minutes to complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This survey asks people who have had cancer about what they expect from new cancer drugs—especially ones approved based on slowing tumor growth (rather than helping people live longer). Your answers could help shape how these drugs are evaluated.
This trial is testing a questionnaire about language used in cancer care. You may be able to help by filling out a survey if you are 18+ and receiving palliative care or ongoing anti-cancer treatment.
This study looks at how to explain the benefits and risks of new cancer drugs in a way that is easier to understand. It helps researchers learn how to communicate better with patients like you.
This is a survey study to understand the needs of young adults (ages 15-39 at diagnosis) who have had cancer treatment. Your answers will help improve care for others like you.
This study collects information about how cancer care affects daily life, treatment side effects, and quality of life, and it stores imaging and related data for future research. You might be able to take part if you’re scheduled for treatment at the center (or you’re a healthy volunteer) and can complete the questionnaires.
This study asks young adults (ages 18–39) receiving cancer care in an infusion clinic to share their experience through a satisfaction survey. It’s meant to understand what helps patients during infusion visits so care can be improved.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.